US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist
  • 5.070
  • +0.150+3.05%
Close Dec 4 16:00 ET
  • 5.120
  • +0.050+0.98%
Post 19:37 ET
1.93BMarket Cap-126750P/E (TTM)

GoodRx Key Stats

GoodRx Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
195.65M
195.25M
-403.81K
Miss Est.
+8.72%
+8.50%
-0.21%
EPS
0.02
0.01
-0.01
Miss Est.
+126.92%
+111.11%
-58.68%
Buy

Nov 30, 2024

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 202.982M--
--2024/Q4-- / 199.733M--
Nov 7, 20242024/Q3195.251M / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 202.982M--
--2024/Q4-- / 199.733M--
Nov 7, 20242024/Q3195.251M / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--

Unlock Free Earnings Estimates

GoodRx Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    50.00%
  • Hold

    42.86%
  • Sell

    7.14%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data